Form 8-K

8-K — FIREFLY NEUROSCIENCE, INC.

Accession: 0001213900-26-046627

Filed: 2026-04-22

Period: 2026-04-16

CIK: 0000803578

SIC: 7372 (SERVICES-PREPACKAGED SOFTWARE)

Item: Entry into a Material Definitive Agreement

Item: Unregistered Sales of Equity Securities

Item: Financial Statements and Exhibits

Documents

8-K — ea0287177-8k_firefly.htm (Primary)

EX-10.1 — FORM OF AMENDED AND RESTATED LOCK-UP AGREEMENT BETWEEN FIREFLY NEUROSCIENCE, INC. AND THE INVESTORS, DATED APRIL 16, 2026 (ea028717701ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0287177-8k_firefly.htm · Sequence: 1

false

0000803578

2026-04-16

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported):

April 16, 2026

FIREFLY NEUROSCIENCE, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-41092

54-1167364

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

1100 Military Road, Kenmore, NY

14217

(Address of principal executive offices)

(Zip Code)

(888) 237-6412

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant

to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to

Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications

pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications

pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

AIFF

The Nasdaq Capital Market

Indicate by check

mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities

Exchange Act of 1934.

Emerging Growth Company ☐

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive

Agreement.

As previously disclosed in the Company’s

Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2026 (the “Prior

8-K”), Firefly Neuroscience, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement,

dated as of March 8, 2026 (the “Purchase Agreement”), with certain accredited investors (the “Initial Investors”),

pursuant to which the Company agreed to issue and sell units (each a “Unit” and, collectively, the “Units”) at

a purchase price of $1.50 per Unit. Under the Purchase Agreement, the Initial Investors were granted the right, but not the obligation,

to purchase in the aggregate up to $18,000,000 of Units in one or more subsequent closings (each, an “Additional Closing”)

within thirty (30) days following the initial closing date.

On April 16, 2026, the Company consummated an

Additional Closing under the Purchase Agreement, pursuant to which the Company issued 5,333,333 Units to an accredited investor (the “Additional

Investor”, together with the Initial Investors, the “Investors”) at a total purchase price of $8,000,000. The Units

were issued on the same terms and conditions as described in the Prior 8-K, including the price of $1.50 per Unit.

The Company and each Investor entered into an

Amended and Restated Lock-Up Agreement, dated as of April 16, 2026 (the “A&R Lock-Up Agreement”), which amended and restated

the Lock-Up Agreement described in the Prior 8-K. Under the A&R Lock-Up Agreement, each Investor has agreed not to transfer any Lock-Up

Securities (as defined in the Prior 8-K) during a thirty (30) day period ending on May 16, 2026 (the “Lock-Up Period”). Upon

expiration of the Lock-Up Period, all Lock-Up Securities will be fully released from the transfer restrictions. The A&R Lock-Up Agreement

otherwise contains substantially the same terms as the original Lock-Up Agreement. The A&R Lock-Up Agreement will automatically terminate

upon the earlier of (i) the expiration of the Lock-Up Period (i.e., May 16, 2026) or (ii) the termination of the Purchase Agreement prior

to any Closing.

In connection with the Additional Closing, the

Investors have also agreed to extend the deadline for the Company to file the Registration Statement (as defined in the Prior 8-K) with

the SEC to May 21, 2026. The Company will use its best efforts to cause the Registration Statement to become effective (i) within 45 calendar

days after filing if the SEC does not review the Registration Statement, or (ii) within 90 calendar days after filing if the SEC reviews

the Registration Statement.

The foregoing description of the terms and conditions

of the A&R Lock-Up Agreement is qualified in its entirety by reference to the full text of the A&R Lock-Up Agreement, a

form of which is filed as Exhibit 10.1 to this Current Report on Form 8-K.

Item 3.02. Unregistered Sales of Equity Securities.

The information set forth in Item 1.01 of

this Current Report on Form 8-K is incorporated by reference herein.

The offer and sale of the securities at the Additional

Closing was conducted as a private placement that is exempt from the registration requirements of the Securities Act of 1933, as amended

(the “Securities Act”), in reliance on Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder.

In connection with the Additional Closing, the Additional Investor represented, among other things, that it qualifies as an “accredited

investor” (as such term is defined in Rule 501(a) of Regulation D under the Securities Act). Accordingly, the offer and sale by

the Company of the securities issued and sold to the Additional Investor have not been registered under the Securities Act or any applicable

state securities or “Blue Sky” laws and, therefore, such securities may not be offered or sold in the United States absent

registration or an exemption from registration under the Securities Act and any applicable state securities or “Blue Sky”

laws.

This Current Report on Form 8-K shall not constitute

an offer to sell or a solicitation of an offer to buy any securities of the Company, nor shall there be any sale of any securities of

the Company in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or

qualification under the securities laws of any such state or other jurisdiction.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

10.1

Form of Amended and Restated Lock-Up Agreement between Firefly Neuroscience, Inc. and the Investors, dated April 16, 2026.

104

Cover Page Interactive Data File (embedded with the Inline XBRL document).

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

Date: April 22, 2026

FIREFLY NEUROSCIENCE, INC.

/s/ Greg Lipschitz

Name:

Greg Lipschitz

Title:

Chief Executive Officer

EX-10.1 — FORM OF AMENDED AND RESTATED LOCK-UP AGREEMENT BETWEEN FIREFLY NEUROSCIENCE, INC. AND THE INVESTORS, DATED APRIL 16, 2026

EX-10.1

Filename: ea028717701ex10-1.htm · Sequence: 2

Exhibit 10.1

AMENDED AND RESTATED LOCK-UP AGREEMENT

This AMENDED AND RESTATED LOCK-UP AGREEMENT (this

“Agreement”) is made and entered into as of April 16, 2026, by and among Firefly Neuroscience, Inc., a Delaware corporation

(the “Company”), and each investor identified on the signature pages hereto (each, an “Investor”

and collectively, the “Investors”). This Agreement amends and restates the Original Lock-Up Agreement (as defined below)

in its entirety.

RECITALS

A. The

Company and the Investors are parties to that certain Securities Purchase Agreement, dated as of March 8, 2026 (the “Purchase

Agreement”), pursuant to which the Investors have agreed to purchase Units consisting of Shares, Warrants and Warrant Shares

(each as defined in the Purchase Agreement) from the Company in a private placement offering (the “Private Placement”).

B. It

is a condition to each Investor’s obligation and the Company’s obligation to consummate each Closing (as defined in the Purchase Agreement)

that the Company and each Investor shall have delivered to each other a duly executed Lock-Up Agreement.

C. The

Company and each Investor previously entered into that certain Lock-Up Agreement, dated as of March 12, 2026 (the “Original Lock-Up

Agreement”), and now desire to amend and restate the Original Lock-Up Agreement in its entirety as set forth herein.

D. The

parties desire to enter into this Agreement to set forth certain restrictions on the transfer and disposition of the Securities (as defined

below) on the terms and conditions set forth herein.

NOW, THEREFORE, in consideration

of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of

which are hereby acknowledged, the parties agree as follows:

1. Definitions.

Capitalized terms used but not defined in this Agreement shall have the meanings ascribed to such terms in the Purchase Agreement. As

used in this Agreement, the following terms shall have the following meanings:

“Lock-Up Securities” means,

with respect to each Investor, (a) the Shares issued to such Investor at any Closing under the Purchase Agreement, (b) the Warrants (including

the Prefunded Warrants, the 150% Warrants and the 200% Warrants) issued to such Investor at any Closing under the Purchase Agreement,

and (c) the Warrant Shares issuable upon exercise of the Warrants issued to such Investor under the Purchase Agreement.

“Lock-Up Period” means the

period commencing on the date of this Agreement and ending on May 16, 2026 (i.e., thirty (30) days after the date of this Agreement).

2. Lock-Up

Restrictions.

(a) During

the Lock-Up Period, each Investor agrees that such Investor will not, directly or indirectly, offer, sell, contract to sell, hypothecate,

pledge or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the

disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by such Investor or

any Affiliate of such Investor or any person in privity with such Investor or any Affiliate of such Investor), or establish or increase

a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange

Act of 1934, as amended (the “Exchange Act”), with respect to, any of the Lock-Up Securities (any such action, a “Transfer”).

(b) [OMITTED]

3. Permitted

Transfers. Notwithstanding the restrictions set forth in Section 2, an Investor may Transfer Lock-Up Securities in accordance with

any of the following, provided that, except with respect to clauses (f) and (g), such Transfer shall not involve a disposition for value

and the transferee agrees in writing with the Company to be bound by the terms of this Agreement for the balance of the applicable restriction

period:

(a) transfers

as a bona fide gift or gifts, including to a charity or educational institution, or to an immediate family member of the Investor;

(b) transfers

to any trust for the direct or indirect benefit of the Investor or the immediate family of the Investor;

the Investor is an individual, transfers to any corporation, partnership, limited liability company or other entity of which the Investor

and/or members of the Investor’s immediate family are the sole equity holders;

(d) if

the Investor is a corporation, partnership, limited liability company, trust or other business entity, (i) transfers to an Affiliate of

the Investor, or (ii) distributions of Lock-Up Securities to limited partners, limited liability company members or stockholders of the

Investor;

(e) if

the Investor is a trust, transfers to the beneficiaries of such trust;

(f) transfers

by will, testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family

of the Investor;

(g) transfers

by operation of law, such as pursuant to a qualified domestic relations order or in connection with a divorce decree; and

(h) transfers

pursuant to a tender offer, merger, stock sale, recapitalization, consolidation or similar transaction involving the Company.

For purposes of this Agreement, “immediate

family” shall mean any relationship by blood, marriage or adoption, not more remote than first cousin.

4. Stop

Transfer Instructions. Each Investor agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent

and registrar against the Transfer of the Lock-Up Securities except in compliance with this Agreement. The Company shall provide written

notice to the Transfer Agent of the restrictions set forth herein and shall instruct the Transfer Agent to decline to transfer any Lock-Up

Securities except in accordance with the terms of this Agreement. Upon the expiration of the Lock-Up Period, the Company shall promptly

instruct the Transfer Agent to remove any stop transfer instructions with respect to the Lock-Up Securities, and shall take all actions

reasonably necessary to permit the Transfer of such Lock-Up Securities in accordance with applicable law.

5. Representations

and Warranties of Each Investor. Each Investor hereby represents and warrants that such Investor has the power and authority to execute,

deliver and perform this Agreement, that such Investor has received adequate consideration therefor, and that such Investor will benefit

from the consummation of the transactions contemplated by the Purchase Agreement.

6. Specific

Performance. Each Investor acknowledges that the execution, delivery and performance of this Agreement is a material inducement to

the Company and each other Investor to consummate the transactions contemplated by the Purchase Agreement, and that the Company and each

Investor shall be entitled to specific performance of such Investor’s obligations hereunder. The parties acknowledge and agree that irreparable

damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms

or were otherwise breached, and that the parties shall be entitled to an injunction or injunctions, specific performance or other equitable

relief to prevent breaches or threatened breaches of this Agreement, without proof of damages or otherwise, this being in addition to

any other remedy to which they are entitled at law or in equity.

7. Termination.

This Agreement shall automatically terminate and be of no further force or effect upon the earlier of (a) the expiration of the Lock-Up

Period (i.e., May 16, 2026) and (b) the termination of the Purchase Agreement prior to any Closing in accordance with its terms.

8. Governing

Law; Jurisdiction; Jury Trial Waiver. This Agreement shall be governed by and construed in accordance with the governing law, jurisdiction,

venue and jury trial waiver provisions set forth in Section 5.1 of the Purchase Agreement, which provisions are incorporated herein by

reference, mutatis mutandis, as if set forth in full herein.

9. Notices.

All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be delivered in accordance

with Section 5.4 of the Purchase Agreement to the respective parties at the addresses set forth on the signature pages hereto (or at such

other addresses as shall be specified by notice given in accordance with Section 5.4 of the Purchase Agreement).

10. Amendments;

Waivers. This Agreement may not be amended or otherwise modified in any respect without the written consent of each of the Company

and the Requisite Holders (as defined in the Purchase Agreement). No waiver of any default with respect to any provision, condition or

requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver

of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder

in any manner impair the exercise of any such right.

11. Successors

and Assigns. This Agreement shall be binding on the successors and assigns of each Investor with respect to the Lock-Up Securities,

and any such successor or assign shall enter into a similar agreement for the benefit of the Company and the other Investors.

12. Severability.

If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded from this

Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance

with its terms.

13. Counterparts.

This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall

constitute one and the same instrument. In the event that any signature is delivered by e-mail delivery of a “.pdf” format

data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)

with the same force and effect as if such “.pdf” signature page were an original thereof.

14. Entire

Agreement. This Agreement amends and restates the Original Lock-Up Agreement in its entirety, and from and after the date hereof,

the Original Lock-Up Agreement shall be of no further force or effect. This Agreement, together with the Purchase Agreement and the other

Transaction Documents, constitutes the entire agreement among the parties with respect to the subject matter hereof and supersedes all

prior agreements, understandings, negotiations and discussions, whether oral or written, of the parties with respect thereto.

[Signature Pages Follow]

IN WITNESS WHEREOF, the parties hereto have caused

this Amended and Restated Lock-Up Agreement to be duly executed by their respective authorized signatories as of the date first written

above.

FIREFLY NEUROSCIENCE, INC.

By:

Name:

Greg Lipschitz

Title:

Chief Executive Officer

INVESTOR:

Print Name Above

Sign Above

If signer is an entity, specify name and title

of authorized signer below:

Name:

Title:

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Apr. 16, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Apr. 16, 2026

Entity File Number

001-41092

Entity Registrant Name

FIREFLY NEUROSCIENCE, INC.

Entity Central Index Key

0000803578

Entity Tax Identification Number

54-1167364

Entity Incorporation, State or Country Code

Entity Address, Address Line One

1100 Military Road

Entity Address, City or Town

Kenmore

Entity Address, State or Province

Entity Address, Postal Zip Code

14217

City Area Code

888

Local Phone Number

237-6412

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.0001 per share

Trading Symbol

AIFF

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration